However, ginsenoside Rg2 activated the ROS-AMPK signaling pathway to inhibit the activation of ERK1/2 and Akt, leading to the inhibition of breast cancer cell proliferation and cell cycle progression and the induction of apoptosis [ 19, 20]. This evidence concerns the gene AKT1 and breast carcinoma.